Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ulinastatin + xuebijing
- Development stage
- Preclinical
- Administration
- Intravenous
01
Overview
A combination therapy consisting of ulinastatin and xuebijing injection. Xuebijing is a Chinese herbal prescription consisting of extracts from five Chinese herbs: Carthamus tinctorius, Radix paeoniae rubra, Ligusticum wallichii, Radix salviae miltiorrhizae, and Radix angelicae sinensis. It is known for activating circulation, removing blood stasis, and clearing toxins. The combination is likely used for inflammatory conditions such as sepsis and systemic inflammatory response syndrome.
02
Targets
Beyond the preview
Go deeper on ulinastatin + xuebijing.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ulinastatin + xuebijing.